4
Changes in Ownership
Fulcrum Therapeutics, Inc. Filed Acc 0000899243-22-024528
Options or other derivatives
- Director acquired 19,000 shares (grant or award)
- Director disposed of 500 shares (other)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Ezekowitz Alan Director | 2022-06-27 | Grant or award · Stock Option (right to buy) | +19,000 | 19,000 | D | ||
| Ezekowitz Alan Director | 2022-06-28 | Other disposition · Stock Option (right to buy) | −500 | 14,500 | D | ||
Loading xslF345X03/doc4.xml…